Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kaleko

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Diabetes|July 27, 2001
Treatment of type 2 diabetes by adenoviral-mediated overexpression of the glucokinase regulatory proteinE D Slosberg, U J Desai, B Fanelli, et al.
Human Gene Therapy|February 1, 1995
In vivo gene delivery and expression of physiological levels of functional human factor VIII in miceS Connelly, T A Smith, G Dhir, et al.
Nature Genetics|December 1, 1993
Adenovirus mediated expression of therapeutic plasma levels of human factor IX in miceT A Smith, M G Mehaffey, D B Kayda, et al.
Diabetes|September 28, 2001
Phenotypic correction of diabetic mice by adenovirus-mediated glucokinase expressionU J Desai, E D Slosberg, B R Boettcher, et al.
Blood|January 3, 2001
Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogsA M Gallo-Penn, P S Shirley, J L Andrews, et al.
Blood|May 23, 1998
Sustained phenotypic correction of murine hemophilia A by in vivo gene therapyS Connelly, J L Andrews, A M Gallo, et al.
Human Gene Therapy|August 14, 1999
In vivo evaluation of an adenoviral vector encoding canine factor VIII: high-level, sustained expression in hemophiliac miceA M Gallo-Penn, P S Shirley, J L Andrews, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Diabetes|July 27, 2001
Treatment of type 2 diabetes by adenoviral-mediated overexpression of the glucokinase regulatory proteinE D Slosberg, U J Desai, B Fanelli, et al.
Human Gene Therapy|February 1, 1995
In vivo gene delivery and expression of physiological levels of functional human factor VIII in miceS Connelly, T A Smith, G Dhir, et al.
Nature Genetics|December 1, 1993
Adenovirus mediated expression of therapeutic plasma levels of human factor IX in miceT A Smith, M G Mehaffey, D B Kayda, et al.
Diabetes|September 28, 2001
Phenotypic correction of diabetic mice by adenovirus-mediated glucokinase expressionU J Desai, E D Slosberg, B R Boettcher, et al.
Blood|January 3, 2001
Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogsA M Gallo-Penn, P S Shirley, J L Andrews, et al.
Blood|May 23, 1998
Sustained phenotypic correction of murine hemophilia A by in vivo gene therapyS Connelly, J L Andrews, A M Gallo, et al.
Human Gene Therapy|August 14, 1999
In vivo evaluation of an adenoviral vector encoding canine factor VIII: high-level, sustained expression in hemophiliac miceA M Gallo-Penn, P S Shirley, J L Andrews, et al.
Pageof 4